It is surprising that with $85,000,000 in cash - no debt - 3 drugs in development - that a larger drug company such as Pfizer or Merck hasn't swooped in to buy Threshold.
pfe has it own problemsnice to see you back in with a strong buy.
On the sidelines since I sold at $3.76. Good luck - add a few shares before Friday on any dips.
Bought 30,000 shares today. Window dressing selling is almost over. If I were a fund manager buying for the next quarter or two Threshold would be at or near the top of my list. I expect Friday and Monday will be nice moves to the upside.